menu
    • menu

    Company profile for PDC*line Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in April 2014 as a spin-off of the French Blood Bank (Etablissement Français du Sang, EFS), PDC*line Pharma is a Belgian-French biotech company that is developing a novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line) pre-loaded with peptides that are derived from target tumor antigens. Based on a robust preclinical package and a first-in-human phase Ib...
    Founded in April 2014 as a spin-off of the French Blood Bank (Etablissement Français du Sang, EFS), PDC*line Pharma is a Belgian-French biotech company that is developing a novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line) pre-loaded with peptides that are derived from target tumor antigens. Based on a robust preclinical package and a first-in-human phase Ib feasibility study in melanoma, PDC*line Pharma is focusing on lung cancer with a new candidate in phase I/II clinical trial (PDC*lung) and neoantigens (PDC*Neo).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PDC*line PharmaFrance Flag
    Country
    Country
    France
    Address
    Address
    29 avenue du Maquis du Grésivaudan 38701 La Tronche
    Telephone
    Telephone
    +33 (0) 4 84 35 05 04
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.pdc-line-pharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PDC*line Pharma Shares Phase I/II Data On Cancer Vaccine At ESMO-IO
    PDC*line Pharma Shares Phase I/II Data On Cancer Vaccine At ESMO-IO

    12 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241212956758/en

    BUSINESSWIRE
    12 Dec 2024
    Share Share
    AACR 2024: PDC*line Pharma Presents Interim Clinical Data
    AACR 2024: PDC*line Pharma Presents Interim Clinical Data

    08 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240408470952/en

    BUSINESSWIRE
    08 Apr 2024
    Share Share
    PDC*line Presents Results From Phase I/II Trial With PDC*lung01
    PDC*line Presents Results From Phase I/II Trial With PDC*lung01

    08 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221205005293/en

    BUSINESSWIRE
    08 Dec 2022
    Share Share
    PDC*line Pharma Raises €17.5 Million in Series B2 Financing Round
    PDC*line Pharma Raises €17.5 Million in Series B2 Financing Round

    06 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211206005018/en

    BUSINESSWIRE
    06 Dec 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search